Provided by Tiger Trade Technology Pte. Ltd.

Inotiv, Inc.

0.3564
-0.0619-14.80%
Volume:502.82K
Turnover:176.06K
Market Cap:12.25M
PE:-0.17
High:0.3990
Open:0.3990
Low:0.3265
Close:0.4183
52wk High:4.51
52wk Low:0.3265
Shares:34.37M
Float Shares:31.21M
Volume Ratio:6.24
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1147
EPS(LYR):-2.1147
ROE:-44.78%
ROA:-2.98%
PB:0.09
PE(LYR):-0.17

Loading ...

Contract research firm Inotiv's Q1 operating loss widens

Reuters
·
3 hours ago

Inotiv Q1 EPS $(0.83) Misses $(0.64) Estimate, Sales $120.879M Miss $120.909M Estimate

Benzinga
·
3 hours ago

Inotiv Inc. Q1 operating loss rises 5.3% to USD 16.3 million

Reuters
·
3 hours ago

BRIEF-Inotiv Q1 Revenue USD 120.9 Million

Reuters
·
3 hours ago

Inotiv Q1 Adjusted Ebitda USD 1.8 Million

THOMSON REUTERS
·
3 hours ago

Inotiv Q1 Net Income USD -28.4 Million

THOMSON REUTERS
·
3 hours ago

Press Release: Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Dow Jones
·
3 hours ago

Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV) and Agilon Health (AGL)

TIPRANKS
·
7 hours ago

Inotiv Inc. gibt bevorstehende Veröffentlichung von Quartalsergebnissen bekannt

Reuters
·
Feb 04

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

GlobeNewswire
·
Feb 04

Inotiv Inc. President and CEO Robert Leasure Jr. Reports Sale of Common Shares

Reuters
·
Feb 04

Analysts’ Top Healthcare Picks: Concentra Group Holdings Parent, Inc. (CON), Inotiv (NOTV)

TIPRANKS
·
Jan 13

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

GlobeNewswire
·
Jan 13

Inotiv Inc. Faces Nasdaq Delisting Risk Over Minimum Bid Price Rule

Reuters
·
Jan 08

Inotiv Partners with VUGENE to Boost AI-Driven Drug Discovery

Reuters
·
Dec 11, 2025

Inotiv Inc. Showcases CRO Growth Strategy and Operational Optimization in Investor Presentation

Reuters
·
Dec 11, 2025

Inotiv Is Maintained at Buy by Lake Street

Dow Jones
·
Dec 05, 2025

Drug testing services firm Inotiv's Q4 revenue beats estimates

Reuters
·
Dec 04, 2025

BRIEF-Inotiv Q4 Revenue USD 138.1 Million

Reuters
·
Dec 04, 2025

Inotiv Q4 Adjusted Ebitda USD 11.8 Million

THOMSON REUTERS
·
Dec 04, 2025